Q3-osavuosiraportti
4 päivää sitten‧42 min
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
11 660 686
Myynti
Määrä
14 022 583
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 500 | - | - | ||
| 7 653 | - | - | ||
| 74 855 | - | - | ||
| 3 300 | - | - | ||
| 649 657 | - | - |
Ylin
0,301VWAP
Alin
0,26VaihtoMäärä
6,4 22 141 906
VWAP
Ylin
0,301Alin
0,26VaihtoMäärä
6,4 22 141 906
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 24.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 26.11. | |
| Merkintäoikeusanti | 2.10. | |
| 2025 Ylimääräinen yhtiökokous | 29.9. | |
| 2025 Q2-osavuosiraportti | 28.8. | |
| 2025 Q1-osavuosiraportti | 14.5. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·2 päivää sitten · MuokattuOver one million shares were traded in the last minute before closing today. Today's daily volume is 3 X the daily average over the last 3 months.·2 päivää sittenYou are right. Couldn't see all the trades on my phone. Wild final sprint 😅
·2 päivää sittenDecent increase in the final action! Fun!
·2 päivää sitten · MuokattuCould it have been a short trader who wanted to transfer their money to the stock market in the USA before the weekend? Remember that tech stocks have had an enormous rebound actually after the rather recent dip. Including today actually. Check stocks like Bitfarms, IREN with vastly many more in the category. Note these fluctuate wildly by nature, so there is a certain risk. I only mention those specifically because I have them in my portfolio instead of things like Nvidia- ·2 päivää sitten · MuokattuCrazy how many shares changed hands at Friday's close 😅 I held onto mine for now. So we'll see if more excitement happens next week. Don't have exact figures. But I think turnover approximately doubled at the auction close. I believe I saw something on the buy side approximately at 11 million shares
- ·2 päivää sittenI just want to add. The company's total value currently is ridiculously low. 162mio. Sek. If the test is sold for 897 dollar per piece, they only need to sell 19,000 tests to have a revenue equivalent to the company's entire value. In the USA, at least 50,000 die annually from that damn unpleasant form of cancer, which is difficult to detect in time. I don't think anyone should expect anything big in q4 and the time leading up to it. I actually only have some faith in q2 2026 But patience in the long term.
·2 päivää sittenThe company's potential is undoubtedly great. Not just in the USA. But they have to start somewhere. “The stock market is a place that transfers money from the impatient to the patient” (quote W.Buffet) Good luck 🤞 By the way, a fierce final closing auction here today.·1 päivä sitten · MuokattuExactly. The old man is right again. One can certainly go in short-term here and get a 100 to 200 percent gain. But my aim is 5-10-15 years ahead. A lot can happen before then. Perhaps they will be overtaken by more hyped companies with more capital available. Perhaps they will be acquired with minimal gain as a result. Perhaps they even go bankrupt; that risk is the biggest explanation for the low share price. But if they end up back on the hyped track, like back when people would pay up to 270 sek for a single Immunovia share. Then the sky is the limit. No risk, no reward is not Buffet at all, But in a company that is nowhere near a P/E of under 10, because they actually don't really earn or generate any revenue at all, then that is the approach and just ignore the small insignificant ripples in the short term. The potential is wildly great, but it can take a long time, like years, to unfold. There are some who like to compare it with Grail. Inc. But with a market cap of 4.3 billion Dollars, they will certainly have to sell a lot of tests to honor that hype. Their test is shotgun-like and has a detection rate of 50 pct. Regarding pancreatic cancer. But again, if they do a capital raise, they can raise more than pocket change for further research. 
·3 päivää sittenPlunges wildly on an otherwise lively market - TERRIBLE rating from here!
·2 päivää sittenIt was not well executed, don't like that guarantors got such an advantage as it borders on indecent. But it's a good way forward now. I think the new CEO actually delivers well on what he says.·2 päivää sittenThe stock market days continue. Many of us were caught off guard by the share issue when the news broke. Including myself. It's difficult to defend oneself against such things. One has to be very skilled at guessing. There might even be a Christmas rally for this stock then, if one is lucky that it latches onto the normal trend. There won't be a new share issue for a very long time anyway, so now the stock should be able to trade normally soon?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q3-osavuosiraportti
4 päivää sitten‧42 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 päivää sitten · MuokattuOver one million shares were traded in the last minute before closing today. Today's daily volume is 3 X the daily average over the last 3 months.·2 päivää sittenYou are right. Couldn't see all the trades on my phone. Wild final sprint 😅
- ·2 päivää sittenDecent increase in the final action! Fun!·2 päivää sitten · MuokattuCould it have been a short trader who wanted to transfer their money to the stock market in the USA before the weekend? Remember that tech stocks have had an enormous rebound actually after the rather recent dip. Including today actually. Check stocks like Bitfarms, IREN with vastly many more in the category. Note these fluctuate wildly by nature, so there is a certain risk. I only mention those specifically because I have them in my portfolio instead of things like Nvidia
- ·2 päivää sitten · MuokattuCrazy how many shares changed hands at Friday's close 😅 I held onto mine for now. So we'll see if more excitement happens next week. Don't have exact figures. But I think turnover approximately doubled at the auction close. I believe I saw something on the buy side approximately at 11 million shares
- ·2 päivää sittenI just want to add. The company's total value currently is ridiculously low. 162mio. Sek. If the test is sold for 897 dollar per piece, they only need to sell 19,000 tests to have a revenue equivalent to the company's entire value. In the USA, at least 50,000 die annually from that damn unpleasant form of cancer, which is difficult to detect in time. I don't think anyone should expect anything big in q4 and the time leading up to it. I actually only have some faith in q2 2026 But patience in the long term.·2 päivää sittenThe company's potential is undoubtedly great. Not just in the USA. But they have to start somewhere. “The stock market is a place that transfers money from the impatient to the patient” (quote W.Buffet) Good luck 🤞 By the way, a fierce final closing auction here today.·1 päivä sitten · MuokattuExactly. The old man is right again. One can certainly go in short-term here and get a 100 to 200 percent gain. But my aim is 5-10-15 years ahead. A lot can happen before then. Perhaps they will be overtaken by more hyped companies with more capital available. Perhaps they will be acquired with minimal gain as a result. Perhaps they even go bankrupt; that risk is the biggest explanation for the low share price. But if they end up back on the hyped track, like back when people would pay up to 270 sek for a single Immunovia share. Then the sky is the limit. No risk, no reward is not Buffet at all, But in a company that is nowhere near a P/E of under 10, because they actually don't really earn or generate any revenue at all, then that is the approach and just ignore the small insignificant ripples in the short term. The potential is wildly great, but it can take a long time, like years, to unfold. There are some who like to compare it with Grail. Inc. But with a market cap of 4.3 billion Dollars, they will certainly have to sell a lot of tests to honor that hype. Their test is shotgun-like and has a detection rate of 50 pct. Regarding pancreatic cancer. But again, if they do a capital raise, they can raise more than pocket change for further research.
- ·3 päivää sittenPlunges wildly on an otherwise lively market - TERRIBLE rating from here!·2 päivää sittenIt was not well executed, don't like that guarantors got such an advantage as it borders on indecent. But it's a good way forward now. I think the new CEO actually delivers well on what he says.·2 päivää sittenThe stock market days continue. Many of us were caught off guard by the share issue when the news broke. Including myself. It's difficult to defend oneself against such things. One has to be very skilled at guessing. There might even be a Christmas rally for this stock then, if one is lucky that it latches onto the normal trend. There won't be a new share issue for a very long time anyway, so now the stock should be able to trade normally soon?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
11 660 686
Myynti
Määrä
14 022 583
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 500 | - | - | ||
| 7 653 | - | - | ||
| 74 855 | - | - | ||
| 3 300 | - | - | ||
| 649 657 | - | - |
Ylin
0,301VWAP
Alin
0,26VaihtoMäärä
6,4 22 141 906
VWAP
Ylin
0,301Alin
0,26VaihtoMäärä
6,4 22 141 906
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 24.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 26.11. | |
| Merkintäoikeusanti | 2.10. | |
| 2025 Ylimääräinen yhtiökokous | 29.9. | |
| 2025 Q2-osavuosiraportti | 28.8. | |
| 2025 Q1-osavuosiraportti | 14.5. |
Datan lähde: Millistream, Quartr
Q3-osavuosiraportti
4 päivää sitten‧42 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 24.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 26.11. | |
| Merkintäoikeusanti | 2.10. | |
| 2025 Ylimääräinen yhtiökokous | 29.9. | |
| 2025 Q2-osavuosiraportti | 28.8. | |
| 2025 Q1-osavuosiraportti | 14.5. |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 päivää sitten · MuokattuOver one million shares were traded in the last minute before closing today. Today's daily volume is 3 X the daily average over the last 3 months.·2 päivää sittenYou are right. Couldn't see all the trades on my phone. Wild final sprint 😅
- ·2 päivää sittenDecent increase in the final action! Fun!·2 päivää sitten · MuokattuCould it have been a short trader who wanted to transfer their money to the stock market in the USA before the weekend? Remember that tech stocks have had an enormous rebound actually after the rather recent dip. Including today actually. Check stocks like Bitfarms, IREN with vastly many more in the category. Note these fluctuate wildly by nature, so there is a certain risk. I only mention those specifically because I have them in my portfolio instead of things like Nvidia
- ·2 päivää sitten · MuokattuCrazy how many shares changed hands at Friday's close 😅 I held onto mine for now. So we'll see if more excitement happens next week. Don't have exact figures. But I think turnover approximately doubled at the auction close. I believe I saw something on the buy side approximately at 11 million shares
- ·2 päivää sittenI just want to add. The company's total value currently is ridiculously low. 162mio. Sek. If the test is sold for 897 dollar per piece, they only need to sell 19,000 tests to have a revenue equivalent to the company's entire value. In the USA, at least 50,000 die annually from that damn unpleasant form of cancer, which is difficult to detect in time. I don't think anyone should expect anything big in q4 and the time leading up to it. I actually only have some faith in q2 2026 But patience in the long term.·2 päivää sittenThe company's potential is undoubtedly great. Not just in the USA. But they have to start somewhere. “The stock market is a place that transfers money from the impatient to the patient” (quote W.Buffet) Good luck 🤞 By the way, a fierce final closing auction here today.·1 päivä sitten · MuokattuExactly. The old man is right again. One can certainly go in short-term here and get a 100 to 200 percent gain. But my aim is 5-10-15 years ahead. A lot can happen before then. Perhaps they will be overtaken by more hyped companies with more capital available. Perhaps they will be acquired with minimal gain as a result. Perhaps they even go bankrupt; that risk is the biggest explanation for the low share price. But if they end up back on the hyped track, like back when people would pay up to 270 sek for a single Immunovia share. Then the sky is the limit. No risk, no reward is not Buffet at all, But in a company that is nowhere near a P/E of under 10, because they actually don't really earn or generate any revenue at all, then that is the approach and just ignore the small insignificant ripples in the short term. The potential is wildly great, but it can take a long time, like years, to unfold. There are some who like to compare it with Grail. Inc. But with a market cap of 4.3 billion Dollars, they will certainly have to sell a lot of tests to honor that hype. Their test is shotgun-like and has a detection rate of 50 pct. Regarding pancreatic cancer. But again, if they do a capital raise, they can raise more than pocket change for further research.
- ·3 päivää sittenPlunges wildly on an otherwise lively market - TERRIBLE rating from here!·2 päivää sittenIt was not well executed, don't like that guarantors got such an advantage as it borders on indecent. But it's a good way forward now. I think the new CEO actually delivers well on what he says.·2 päivää sittenThe stock market days continue. Many of us were caught off guard by the share issue when the news broke. Including myself. It's difficult to defend oneself against such things. One has to be very skilled at guessing. There might even be a Christmas rally for this stock then, if one is lucky that it latches onto the normal trend. There won't be a new share issue for a very long time anyway, so now the stock should be able to trade normally soon?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
11 660 686
Myynti
Määrä
14 022 583
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 500 | - | - | ||
| 7 653 | - | - | ||
| 74 855 | - | - | ||
| 3 300 | - | - | ||
| 649 657 | - | - |
Ylin
0,301VWAP
Alin
0,26VaihtoMäärä
6,4 22 141 906
VWAP
Ylin
0,301Alin
0,26VaihtoMäärä
6,4 22 141 906
Välittäjätilasto
Dataa ei löytynyt